The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Galectin 3 and its binding protein in rheumatoid arthritis
Abstract
Objective: To characterize the expression pattern and role of galectin 3 and galectin 3 binding protein (G3BP) in rheumatoid arthritis (RA), in comparison with galectin 1, and to explore whether soluble galectin 3 and G3BP, investigated in serum, synovial fluid, or cell culture supernatant, are associated with disease. Methods: Synovial tissues from patients with RA or osteoarthritis (OA), as well as from healthy controls, were analyzed for galectins 1 and 3 and G3BP by in situ hybridization and immunohistochemistry. Levels of galectin 3 and G3BP in serum and synovial fluid from patients with RA and OA and controls, as well as in cell culture supernatants, were determined by enzyme‐linked immunosorbent assay (ELISA). In vitro, the intracellular expression of galectin 3 in RA and OA synovial fibroblasts after modulation with tumor necrosis factor α (TNFα), interleukin‐1β (IL‐1β), and anti‐CD40 monoclonal antibodies was measured by flow cytometry. Results: In RA, galectin 3 messenger RNA and protein stained throughout the synovial membrane, whereas G3BP was particularly expressed at sites of bone destruction. In contrast, the expression of galectin 1 was not uniform in different RA specimens, and was never found at sites of invasion. In OA and normal synovial tissues, only a small number of cells were positive for galectins and/or G3BP. Galectin 3 was elevated in RA sera and synovial fluids, whereas G3BP was increased in RA synovial fluids only. In RA, serum galectin 3 correlated with C‐reactive protein levels, whereas G3BP was associated with joint destruction and/or synovial cell activation as measured by the levels of cartilage oligomeric matrix protein. In vitro, RA synovial fibroblasts showed an increased release of galectin 3 into culture medium, as measured by ELISA, but decreased secretion of G3BP. In RA synovial fibroblasts with low basal expression of galectin 3, TNFα increased its intracellular level in a dose‐dependent manner. In contrast, IL‐1β or anti‐CD40 monoclonal antibodies showed no effect. Conclusion: Our data indicate that galectin 3 and G3BP are not only involved in inflammation, but also contribute to the activation of synovial fibroblasts. The intracellular accumulation of galectin 3 can be enhanced by TNFα. Thus, galectin 3 and G3BP represent novel markers of disease activity in RA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arnett, F. C., Edworthy, S. M., Bloch, D. A., Mcshane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., et al. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310302 · Cited by 19,752
Revised Criteria for the Classification of Rheumatoid Arthritis
Arnett, F. C. (1990) · Orthopaedic Nursing · doi:10.1097/00006416-199003000-00011 · Cited by 7,723
Expression of galectin-3 modulates T-cell growth and apoptosis.
Yang, R. Y., Hsu, D. K., & Liu, F. T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6737 · Cited by 789
Self-citationIntracellular functions of galectins
Liu, F. (2002) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00313-6 · Cited by 675
Self-citationGalectins: versatile modulators of cell adhesion, cell proliferation, and cell death
Perillo, N. L., Marcus, M. E., & Baum, L. G. (1998) · Journal of Molecular Medicine · doi:10.1007/s001090050232 · Cited by 640
Human Galectin-3 Is a Novel Chemoattractant for Monocytes and Macrophages
Sano, H., Hsu, D. K., Yu, L., Apgar, J. R., Kuwabara, I., Yamanaka, T., Hirashima, M., & Liu, F.-T. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.4.2156 · Cited by 521
Self-citationTargeted Disruption of the Galectin-3 Gene Results in Attenuated Peritoneal Inflammatory Responses
Hsu, D. K., Yang, R.-Y., Pan, Z., Yu, L., Salomon, D. R., Fung-Leung, W.-P., & Liu, F.-T. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64975-9 · Cited by 428
Self-citationGalectins as modulators of cell adhesion
Colin Hughes, R. (2001) · Biochimie · doi:10.1016/s0300-9084(01)01289-5 · Cited by 417
Galectin-3 promotes adhesion of human neutrophils to laminin
Kuwabara, I., & Liu, F. T. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.10.3939 · Cited by 329
Self-citationGalectin-3 Phosphorylation Is Required for Its Anti-apoptotic Function and Cell Cycle Arrest
Yoshii, T., Fukumori, T., Honjo, Y., Inohara, H., Kim, H.-R. C., & Raz, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107668200 · Cited by 252
Cited by
Galectin-3: An open-ended story
Dumic, J., Dabelic, S., & Flögel, M. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2005.12.020 · Cited by 1,169
Turning 'sweet' on immunity: galectin–glycan interactions in immune tolerance and inflammation
Rabinovich, G. A., & Toscano, M. A. (2009) · Nature Reviews Immunology · doi:10.1038/nri2536 · Cited by 904
Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z
Sciacchitano, S., Lavra, L., Morgante, A., Ulivieri, A., Magi, F., De Francesco, G., Bellotti, C., Salehi, L., & Ricci, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020379 · Cited by 377
Molecular and cellular basis of rheumatoid joint destruction
Karouzakis, E., Neidhart, M., Gay, R. E., & Gay, S. (2006) · Immunology Letters · doi:10.1016/j.imlet.2006.04.011 · Cited by 167
Self-citationUchino, Y., Woodward, A. M., Mauris, J., Peterson, K., Verma, P., Nilsson, U. J., Rajaiya, J., & Argüeso, P. (2018) · Immunology · doi:10.1111/imm.12899 · Cited by 31
Akkaya, H. Ü., Yılmaz, H. E., Narin, F., & Sağlam, M. (2022) · Journal of Periodontology · doi:10.1002/jper.21-0137 · Cited by 25
Metadata
- Authors
- Ohshima, S., Kuchen, S., Seemayer, C. A., Kyburz, D., Hirt, A., Klinzing, S., Michel, B. A., Gay, R. E., Liu, F., Gay, S., & Neidhart, M.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2003-10
- Volume
- 48
- Issue
- 10
- Pages
- 2788-2795
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2022223746
- Cited by
- 302
- References
- 33
- FWCI
- 12.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.